Key variants in genes like GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) may influence how a person's body processes GLP-1 medications and responds to dose adjustments
Hypoglycemia represents a serious acute risk, as IGF-1 DES possesses potent insulin-like metabolic effects including enhanced glucose uptake into muscle and adipose tissue, increased glycogen synthesis, and suppression of hepatic glucose output
In patients with persistent hyperglycaemia, in particular those without weight concerns, consideration could be given to commencing insulin therapy meanwhile
I can't say enough about how Tami and Liz have wonderfully supported me on this journey
Rita Kapoor Promote Health and Recovery Through IV Therapy What is IV therapy, and how does it work